U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496450) titled 'A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults' on March 22.
Brief Summary: The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults >=18 years of age.
Study Start Date: March 23
Study Type: INTERVENTIONAL
Condition:
Influenza
Intervention:
BIOLOGICAL: mRNA-1018-H5
Sterile liquid for injection.
BIOLOGICAL: Placebo
Sterile liquid for injection.
Recruitment Status: RECRUITING
Sponsor: ModernaTX, Inc.
Disclaimer: Curated by HT Syndication....